Related Experiment Video
Updated: Aug 19, 2025

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
Acinetobacter baumannii reinforces the pathogenesis by promoting IL-17 production in a mouse pneumonia model
Yangyang Zhou1, Chuanying Xiang1, Ning Wang1
1West China Biopharmaceutical Research Institute, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Abstract:
Interleukin-17 (IL-17) is involved in host defense against bacterial infection. Little is known about the role of IL-17 in A. baumannii-infected pneumonia. Our objective was to investigate the role of IL-17 in pulmonary A. baumannii infection in a mouse model. We infected C57BL/6 mice intra-tracheally (i.t.) with A. baumannii to establish pneumonia model and found A. baumannii infection elevated IL-17 expression in lungs. IL-17-deficient (Il17-/-) mice were resistant to pulmonary A. baumannii infection, showing improved mice survival, reduced bacteria burdens, and alleviated lung inflammation. Further, treatment of A. baumannii-infected Il17-/- mice with IL-17 exacerbated the severity of pneumonia. These data suggest a pathogenic role of IL-17 in pulmonary A. baumannii infection. Further, the infiltration and phagocytic function of neutrophils in broncho-alveolar lavage fluid were detected by flow cytometry. The results showed that Il17-/- mice had increased neutrophil infiltration and enhanced phagocytosis in neutrophils at the early time of infection. Treatment of mice with IL-17 suppressed phagocytic function of neutrophils. All data suggest that IL-17 promotes susceptibility of mice to pulmonary A. baumannii infection by suppressing neutrophil phagocytosis at early time of infection. Targeting IL-17 might be a potential therapeutic strategy in controlling the outcome of A. baumannii pneumonia.
Insights
Interleukin-17 (IL-17) exacerbates Acinetobacter baumannii pneumonia by suppressing neutrophil function. Targeting IL-17 may improve outcomes for this serious bacterial lung infection.
Area of Science:
- Immunology
- Infectious Diseases
- Pulmonology
Background:
- Interleukin-17 (IL-17) plays a role in host defense against bacterial infections.
- The specific role of IL-17 in Acinetobacter baumannii pneumonia is not well understood.
Purpose of the Study:
- To investigate the role of IL-17 in a mouse model of pulmonary Acinetobacter baumannii infection.
- To determine the impact of IL-17 on host defense mechanisms, particularly neutrophil function.
Main Methods:
- Intra-tracheal instillation of Acinetobacter baumannii in C57BL/6 mice to induce pneumonia.
- Comparison of wild-type and IL-17-deficient (Il17-/-) mice.
- Analysis of survival, bacterial burden, lung inflammation, and neutrophil infiltration and phagocytosis via flow cytometry.
Main Results:
- Acinetobacter baumannii infection increased IL-17 expression in the lungs.
- IL-17-deficient mice exhibited increased survival, reduced bacterial load, and less lung inflammation compared to wild-type mice.
- IL-17 treatment exacerbated pneumonia severity and suppressed neutrophil phagocytic function in infected mice.
Conclusions:
- IL-17 plays a pathogenic role in Acinetobacter baumannii pneumonia by impairing neutrophil phagocytosis.
- Targeting IL-17 presents a potential therapeutic strategy for managing Acinetobacter baumannii pneumonia.
More Related Videos
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
08:16An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses
Published on: July 7, 2017